- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Ranibizumab market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Ranibizumab market size is estimated to be worth US$ 3549.5 million in 2021 and is forecast to a readjusted size of USD 1768.3 million by 2028 with a CAGR of -9.5% during review period. Wet AMD accounting for % of the Ranibizumab global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Glass Vial segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Ranibizumab include Roche, Novartis, , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Ranibizumab market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Glass Vial
Prefilled Syringe
Market segment by Application, can be divided into
Wet AMD
Complications of Diabetes
RVO
Others
Market segment by players, this report covers
Roche
Novartis
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Ranibizumab product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Ranibizumab, with revenue, gross margin and global market share of Ranibizumab from 2019 to 2022.
Chapter 3, the Ranibizumab competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Ranibizumab market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Ranibizumab research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Ranibizumab
1.2 Classification of Ranibizumab by Type
1.2.1 Overview: Global Ranibizumab Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Ranibizumab Revenue Market Share by Type in 2021
1.2.3 Glass Vial
1.2.4 Prefilled Syringe
1.3 Global Ranibizumab Market by Application
1.3.1 Overview: Global Ranibizumab Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Wet AMD
1.3.3 Complications of Diabetes
1.3.4 RVO
1.3.5 Others
1.4 Global Ranibizumab Market Size & Forecast
1.5 Global Ranibizumab Market Size and Forecast by Region
1.5.1 Global Ranibizumab Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Ranibizumab Market Size by Region, (2017-2022)
1.5.3 North America Ranibizumab Market Size and Prospect (2017-2028)
1.5.4 Europe Ranibizumab Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Ranibizumab Market Size and Prospect (2017-2028)
1.5.6 South America Ranibizumab Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Ranibizumab Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Ranibizumab Market Drivers
1.6.2 Ranibizumab Market Restraints
1.6.3 Ranibizumab Trends Analysis
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Ranibizumab Product and Solutions
2.1.4 Roche Ranibizumab Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Roche Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Ranibizumab Product and Solutions
2.2.4 Novartis Ranibizumab Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Novartis Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Ranibizumab Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Ranibizumab Players Market Share in 2021
3.2.2 Top 10 Ranibizumab Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Ranibizumab Players Head Office, Products and Services Provided
3.4 Ranibizumab Mergers & Acquisitions
3.5 Ranibizumab New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Ranibizumab Revenue and Market Share by Type (2017-2022)
4.2 Global Ranibizumab Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Ranibizumab Revenue Market Share by Application (2017-2022)
5.2 Global Ranibizumab Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Ranibizumab Revenue by Type (2017-2028)
6.2 North America Ranibizumab Revenue by Application (2017-2028)
6.3 North America Ranibizumab Market Size by Country
6.3.1 North America Ranibizumab Revenue by Country (2017-2028)
6.3.2 United States Ranibizumab Market Size and Forecast (2017-2028)
6.3.3 Canada Ranibizumab Market Size and Forecast (2017-2028)
6.3.4 Mexico Ranibizumab Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Ranibizumab Revenue by Type (2017-2028)
7.2 Europe Ranibizumab Revenue by Application (2017-2028)
7.3 Europe Ranibizumab Market Size by Country
7.3.1 Europe Ranibizumab Revenue by Country (2017-2028)
7.3.2 Germany Ranibizumab Market Size and Forecast (2017-2028)
7.3.3 France Ranibizumab Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Ranibizumab Market Size and Forecast (2017-2028)
7.3.5 Russia Ranibizumab Market Size and Forecast (2017-2028)
7.3.6 Italy Ranibizumab Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Ranibizumab Revenue by Type (2017-2028)
8.2 Asia-Pacific Ranibizumab Revenue by Application (2017-2028)
8.3 Asia-Pacific Ranibizumab Market Size by Region
8.3.1 Asia-Pacific Ranibizumab Revenue by Region (2017-2028)
8.3.2 China Ranibizumab Market Size and Forecast (2017-2028)
8.3.3 Japan Ranibizumab Market Size and Forecast (2017-2028)
8.3.4 South Korea Ranibizumab Market Size and Forecast (2017-2028)
8.3.5 India Ranibizumab Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Ranibizumab Market Size and Forecast (2017-2028)
8.3.7 Australia Ranibizumab Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Ranibizumab Revenue by Type (2017-2028)
9.2 South America Ranibizumab Revenue by Application (2017-2028)
9.3 South America Ranibizumab Market Size by Country
9.3.1 South America Ranibizumab Revenue by Country (2017-2028)
9.3.2 Brazil Ranibizumab Market Size and Forecast (2017-2028)
9.3.3 Argentina Ranibizumab Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Ranibizumab Revenue by Type (2017-2028)
10.2 Middle East & Africa Ranibizumab Revenue by Application (2017-2028)
10.3 Middle East & Africa Ranibizumab Market Size by Country
10.3.1 Middle East & Africa Ranibizumab Revenue by Country (2017-2028)
10.3.2 Turkey Ranibizumab Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Ranibizumab Market Size and Forecast (2017-2028)
10.3.4 UAE Ranibizumab Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Ranibizumab Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Ranibizumab Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Ranibizumab Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Ranibizumab Revenue (USD Million) by Region (2017-2022)
Table 5. Global Ranibizumab Revenue Market Share by Region (2023-2028)
Table 6. Roche Corporate Information, Head Office, and Major Competitors
Table 7. Roche Major Business
Table 8. Roche Ranibizumab Product and Solutions
Table 9. Roche Ranibizumab Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Novartis Corporate Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Ranibizumab Product and Solutions
Table 13. Novartis Ranibizumab Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Global Ranibizumab Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 15. Global Ranibizumab Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 16. Breakdown of Ranibizumab by Company Type (Tier 1, Tier 2 and Tier 3)
Table 17. Ranibizumab Players Head Office, Products and Services Provided
Table 18. Ranibizumab Mergers & Acquisitions in the Past Five Years
Table 19. Ranibizumab New Entrants and Expansion Plans
Table 20. Global Ranibizumab Revenue (USD Million) by Type (2017-2022)
Table 21. Global Ranibizumab Revenue Share by Type (2017-2022)
Table 22. Global Ranibizumab Revenue Forecast by Type (2023-2028)
Table 23. Global Ranibizumab Revenue by Application (2017-2022)
Table 24. Global Ranibizumab Revenue Forecast by Application (2023-2028)
Table 25. North America Ranibizumab Revenue by Type (2017-2022) & (USD Million)
Table 26. North America Ranibizumab Revenue by Type (2023-2028) & (USD Million)
Table 27. North America Ranibizumab Revenue by Application (2017-2022) & (USD Million)
Table 28. North America Ranibizumab Revenue by Application (2023-2028) & (USD Million)
Table 29. North America Ranibizumab Revenue by Country (2017-2022) & (USD Million)
Table 30. North America Ranibizumab Revenue by Country (2023-2028) & (USD Million)
Table 31. Europe Ranibizumab Revenue by Type (2017-2022) & (USD Million)
Table 32. Europe Ranibizumab Revenue by Type (2023-2028) & (USD Million)
Table 33. Europe Ranibizumab Revenue by Application (2017-2022) & (USD Million)
Table 34. Europe Ranibizumab Revenue by Application (2023-2028) & (USD Million)
Table 35. Europe Ranibizumab Revenue by Country (2017-2022) & (USD Million)
Table 36. Europe Ranibizumab Revenue by Country (2023-2028) & (USD Million)
Table 37. Asia-Pacific Ranibizumab Revenue by Type (2017-2022) & (USD Million)
Table 38. Asia-Pacific Ranibizumab Revenue by Type (2023-2028) & (USD Million)
Table 39. Asia-Pacific Ranibizumab Revenue by Application (2017-2022) & (USD Million)
Table 40. Asia-Pacific Ranibizumab Revenue by Application (2023-2028) & (USD Million)
Table 41. Asia-Pacific Ranibizumab Revenue by Region (2017-2022) & (USD Million)
Table 42. Asia-Pacific Ranibizumab Revenue by Region (2023-2028) & (USD Million)
Table 43. South America Ranibizumab Revenue by Type (2017-2022) & (USD Million)
Table 44. South America Ranibizumab Revenue by Type (2023-2028) & (USD Million)
Table 45. South America Ranibizumab Revenue by Application (2017-2022) & (USD Million)
Table 46. South America Ranibizumab Revenue by Application (2023-2028) & (USD Million)
Table 47. South America Ranibizumab Revenue by Country (2017-2022) & (USD Million)
Table 48. South America Ranibizumab Revenue by Country (2023-2028) & (USD Million)
Table 49. Middle East & Africa Ranibizumab Revenue by Type (2017-2022) & (USD Million)
Table 50. Middle East & Africa Ranibizumab Revenue by Type (2023-2028) & (USD Million)
Table 51. Middle East & Africa Ranibizumab Revenue by Application (2017-2022) & (USD Million)
Table 52. Middle East & Africa Ranibizumab Revenue by Application (2023-2028) & (USD Million)
Table 53. Middle East & Africa Ranibizumab Revenue by Country (2017-2022) & (USD Million)
Table 54. Middle East & Africa Ranibizumab Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Ranibizumab Picture
Figure 2. Global Ranibizumab Revenue Market Share by Type in 2021
Figure 3. Glass Vial
Figure 4. Prefilled Syringe
Figure 5. Ranibizumab Revenue Market Share by Application in 2021
Figure 6. Wet AMD Picture
Figure 7. Complications of Diabetes Picture
Figure 8. RVO Picture
Figure 9. Others Picture
Figure 10. Global Ranibizumab Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 11. Global Ranibizumab Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Ranibizumab Revenue Market Share by Region (2017-2028)
Figure 13. Global Ranibizumab Revenue Market Share by Region in 2021
Figure 14. North America Ranibizumab Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Europe Ranibizumab Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Asia-Pacific Ranibizumab Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. South America Ranibizumab Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Middle East and Africa Ranibizumab Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Ranibizumab Market Drivers
Figure 20. Ranibizumab Market Restraints
Figure 21. Ranibizumab Market Trends
Figure 22. Roche Recent Developments and Future Plans
Figure 23. Novartis Recent Developments and Future Plans
Figure 24. Global Ranibizumab Revenue Share by Players in 2021
Figure 25. Ranibizumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 26. Global Top 3 Players Ranibizumab Revenue Market Share in 2021
Figure 27. Global Top 10 Players Ranibizumab Revenue Market Share in 2021
Figure 28. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 29. Global Ranibizumab Revenue Share by Type in 2021
Figure 30. Global Ranibizumab Market Share Forecast by Type (2023-2028)
Figure 31. Global Ranibizumab Revenue Share by Application in 2021
Figure 32. Global Ranibizumab Market Share Forecast by Application (2023-2028)
Figure 33. North America Ranibizumab Sales Market Share by Type (2017-2028)
Figure 34. North America Ranibizumab Sales Market Share by Application (2017-2028)
Figure 35. North America Ranibizumab Revenue Market Share by Country (2017-2028)
Figure 36. United States Ranibizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 37. Canada Ranibizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 38. Mexico Ranibizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 39. Europe Ranibizumab Sales Market Share by Type (2017-2028)
Figure 40. Europe Ranibizumab Sales Market Share by Application (2017-2028)
Figure 41. Europe Ranibizumab Revenue Market Share by Country (2017-2028)
Figure 42. Germany Ranibizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. France Ranibizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. United Kingdom Ranibizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Russia Ranibizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Italy Ranibizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Asia-Pacific Ranibizumab Sales Market Share by Type (2017-2028)
Figure 48. Asia-Pacific Ranibizumab Sales Market Share by Application (2017-2028)
Figure 49. Asia-Pacific Ranibizumab Revenue Market Share by Region (2017-2028)
Figure 50. China Ranibizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Japan Ranibizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. South Korea Ranibizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. India Ranibizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Southeast Asia Ranibizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Australia Ranibizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. South America Ranibizumab Sales Market Share by Type (2017-2028)
Figure 57. South America Ranibizumab Sales Market Share by Application (2017-2028)
Figure 58. South America Ranibizumab Revenue Market Share by Country (2017-2028)
Figure 59. Brazil Ranibizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Argentina Ranibizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Middle East and Africa Ranibizumab Sales Market Share by Type (2017-2028)
Figure 62. Middle East and Africa Ranibizumab Sales Market Share by Application (2017-2028)
Figure 63. Middle East and Africa Ranibizumab Revenue Market Share by Country (2017-2028)
Figure 64. Turkey Ranibizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Saudi Arabia Ranibizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. UAE Ranibizumab Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Methodology
Figure 68. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
